TDP1 Inhibitors

TDP1 Inhibitors, in this context, are chemicals that indirectly affect TDP1 by influencing DNA repair mechanisms and the cellular response to DNA damage. TDP1 plays a crucial role in repairing DNA damage caused by trapped topoisomerase-DNA complexes, and its function is closely linked to the cellular mechanisms that detect and respond to DNA damage. Topotecan and Camptothecin are topoisomerase I inhibitors, which can increase the occurrence of DNA lesions that require TDP1 involvement for repair. By inhibiting topoisomerase I, these drugs indirectly increase the substrate load and demand for TDP1's activity. Etoposide, a topoisomerase II inhibitor, alters the landscape of DNA damage in the cell, impacting TDP1-involved pathways. PARP inhibitors like Olaparib and Veliparib affect the repair of single-strand DNA breaks, which could indirectly require TDP1 activity for resolving complex DNA damage scenarios. ATR and ATM inhibitors, such as VE-821 and KU-55933, modulate the cellular response to DNA damage, indirectly influencing TDP1's role in these pathways. NU7441 and Wortmannin, inhibitors of DNA-PK, impact DNA double-strand break repair mechanisms, involving TDP1 in alternative repair pathways. Mirin affects MRE11, a protein involved in the processing of DNA double-strand breaks, which could indirectly necessitate TDP1 activity. Caffeine, known for its broad effects on DNA damage response pathways, could influence the activity of TDP1 indirectly through its impact on these pathways. Lastly, Hydroxyurea induces replication stress, increasing the reliance on TDP1 for resolving DNA lesions that arise during replication stress.